Medication Adherence Solutions for the Big Data Age

IMC makes IoT connected Med-ic Smart Blisters, eCAP Smart Medication Bottles, CoolBlue temperature aware Smart Pack for syringes and custom products. IMC is active in the AI enabled digital health field, and offers its own secure CertiScan clinical research adherence cloud as well as the Medopad digital health platform worldwide. IMCs latest Lilipond AI project is aimed at detecting opiate abuse early enough to avoid addiction; focussing on prevention. Our solutions are connected through our CertiScan Adherence Cloud and partnerships with global health platforms.

Unrivalled 3 sigma dose event accuracy, support track and trace logistics, detect tampering, fraud, diversion and much more.

Experience the latest generation of award-winning Smart Packaging.  The power of connected smart packaging and innovative adherence technologies is now in the hands of the patient. Global digital mobile health platforms connect patients and their data directly with their care teams to assist in behavioural modification and support both AI and human clinical decisions.

“Allowing nonadherence to go unaddressed results in spurious data that can lead to erroneous conclusions (underestimation) of an IND’s effectiveness, with resulting downstream effects on all those for whom the drug, if approved, will ultimately be prescribed.” Allan Wilson, MD PhD., President and co-founder of IMC.